Profile of a Contrarian
Understanding the mind behind the trades.
Michael Burry, an M.D. from Vanderbilt turned legendary investor, is renowned for his deep, data-driven analysis and unwavering contrarian convictions. Entirely self-taught, his investment style is, in his own words, “100% based on the concept of a margin of safety.”
His fame was cemented by his prescient bet against the 2008 subprime mortgage crisis, chronicled in “The Big Short.” This defined his public persona as “Cassandra”—a prophet of financial doom. He's known for issuing stark warnings like “Sell” on Twitter, only to delete his posts moments later, reinforcing his enigmatic and data-driven approach.
Margin of Safety
The foundational principle: purchase securities for significantly less than their calculated intrinsic value.
“Road Kill” Investing
Actively seeks unpopular, overlooked companies, aiming to buy when they look like “road kill” and sell when polished up.
Forensic Research
A deep, clinical examination of financials, prioritizing free cash flow over easily manipulated metrics like P/E ratios.
The Great Repositioning
A 180-degree pivot from maximum bearishness in Q1 to targeted bullishness in Q2 2025.
Q1: The Fortress
A maximum-bearish stance, liquidating nearly all equities to bet against the market's most speculative sectors: the AI bubble (Nvidia) and the China reopening narrative (BABA, JD). This proved prescient, sidestepping the April 'Liberation Day' tariff sell-off.
Q2: The Offensive
The fortress was completely dismantled. All bearish puts were closed and capital was redeployed into a concentrated portfolio of 6 stocks and 9 bullish call options, targeting beaten-down market leaders.
Scion's Q2 2025 Portfolio
A detailed breakdown of the new high-conviction bets.
Common Stock Holdings
| Ticker | Company | Shares | Market Value | Portfolio Weight |
|---|---|---|---|---|
| EL | Estée Lauder Companies Inc. | 150,000 | $12,120,000 | 21.55% |
| LULU | Lululemon Athletica Inc. | 50,000 | $11,879,000 | 21.12% |
| BRKR | Bruker Corporation | 250,000 | $10,300,000 | 18.31% |
| REGN | Regeneron Pharmaceuticals, Inc. | 15,000 | $7,875,000 | 14.00% |
| MELI | MercadoLibre, Inc. | 3,000 | $7,840,890 | 13.94% |
| UNH | UnitedHealth Group Inc. | 20,000 | $6,239,400 | 11.09% |
Leveraged Bets: Call Options
| Ticker | Company | Notional Value |
|---|---|---|
| UNH | UnitedHealth Group Inc. | ~$109,200,000 |
| REGN | Regeneron Pharmaceuticals, Inc. | ~$105,000,000 |
| LULU | Lululemon Athletica Inc. | ~$95,000,000 |
| META | Meta Platforms, Inc. | ~$73,800,000 |
| EL | Estée Lauder Companies Inc. | ~$40,400,000 |
| JD | JD.com, Inc. | ~$32,600,000 |
| BABA | Alibaba Group Holding Ltd. | ~$28,000,000 |
| ASML | ASML Holding N.V. | Value not specified |
| VFC | VF Corporation | Value not specified |
Anatomy of Conviction
Deconstructing the rationale behind Burry's key investments.
Healthcare on the Operating Table
Battered Premium Brands
Tactical & Growth Plays
The Verdict
What does this dramatic shift signal about Burry's market outlook?
From Macro-Bear to Micro-Bull
Michael Burry is no longer positioned for a systemic market crash. He has shifted from a top-down, macro-focused bearishness to a bottom-up, micro-focused bullishness, picking through the wreckage of what he appears to view as a targeted correction.
Concentration & Leverage Risk
This new portfolio carries significant idiosyncratic risk. It is highly concentrated in challenged sectors and uses extensive leverage via call options, which require correct timing to be profitable. This is a high-stakes bet on a recovery in specific, beaten-down names.
Final Assessment: The Cassandra has ceased his warnings of a broad storm and has begun to sift through the rubble, having identified the specific targets he believes will rise again.